Investors may be wondering whether Moderna's current share price reflects its true value, or if the market is still trying to ...
For FY 2026, the company is targeting up to 10% growth over its 2025 revenue. ・Moderna’s Q1 net product sales rose on ...
Barchart on MSN
Is Wall Street bullish or bearish on Moderna stock?
Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that provides messenger RNA medicines. Valued ...
CHONGQING, CHINA - JULY 29: In this photo illustration, a smartphone displays the logo of Moderna Inc. (NASDAQ: MRNA), a biotechnology company known for its mRNA-based vaccines and therapeutics, in ...
Moderna (MRNA) ended the recent trading session at $51.30, demonstrating a -1.54% change from the preceding day's closing price. This change lagged the S&P 500's 0.62% gain on the day. Meanwhile, the ...
Moderna Inc. (NASDAQ:MRNA) is one of the best performing S&P 500 stocks so far in 2026. On April 21, the European Commission ...
Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading this week, for the July 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...
Looking ahead to 2030, our model projects MRNA could trade at an average price of $51.58, with a potential range between $38.69 and $64.48. This represents a potential 10.4% return from today's price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results